However, no significant correlations were observed between SNX17 expression and other clinicopathological factors including age, tumor size, TNM grade, cirrhosis status, serum alpha-fetoprotein (AFP) level, vessel carcinoma embolus (VCE), HBV positivity status, portal vein tumor thrombus (PVTT) and vessel carcinoma embolus (VCE), capsule status (Supplementary Table S5). The gene discussed is AFP; the disease is Cirrhosis.